Literature DB >> 18991052

A case of anterior ischemic optic neuropathy associated with Fabry's disease.

Ken Kumagai1, Yoshinori Mitamura2, Satoshi Mizunoya3, Naoya Fujimoto1, Shuichi Yamamoto1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18991052     DOI: 10.1007/s10384-008-0572-4

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


× No keyword cloud information.
  5 in total

1.  Central retinal artery occlusion complicating Fabry's disease.

Authors:  N A Sher; W Reiff; R D Letson; R J Desnick
Journal:  Arch Ophthalmol       Date:  1978-05

2.  Ocular manifestations in angiokeratoma corporis diffusum (Fabry).

Authors:  C M Velzeboer; W P de Groot
Journal:  Br J Ophthalmol       Date:  1971-10       Impact factor: 4.638

3.  Fabry's disease: ocular findings in a female carrier. A light and electron microscopy study.

Authors:  T A Weingeist; F C Blodi
Journal:  Arch Ophthalmol       Date:  1971-02

4.  Ocular manifestations in Fabry disease: a survey of 32 hemizygous male patients.

Authors:  Christophe Orssaud; Jean Dufier; Dominique Germain
Journal:  Ophthalmic Genet       Date:  2003-09       Impact factor: 1.803

5.  Ischemic optic neuropathy in a female carrier with Fabry's disease.

Authors:  H Abe; T Sakai; S Sawaguchi; S Hasegawa; M Takagi; T Yoshizawa; T Usui; Y Horikawa
Journal:  Ophthalmologica       Date:  1992       Impact factor: 3.250

  5 in total
  2 in total

1.  Cilioretinal artery occlusion and anterior ischemic optic neuropathy as the initial presentation in a child female carrier of Fabry disease.

Authors:  M Giray Ersoz; Gamze Ture
Journal:  Int Ophthalmol       Date:  2017-03-09       Impact factor: 2.031

2.  Frequency Doubling Technology Visual Field Loss in Fabry Subjects Related to Retinal Ganglion Cell Function as Explored by ERG and OSOME.

Authors:  Langis Michaud; Marie-Lou Garon; Pierre Forcier; Vasile Diaconu
Journal:  Clin Ophthalmol       Date:  2022-06-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.